Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
Close

Search

Subscribe
Popular Blood Pressure Tablets Under Class II Recall - WSB-TV Channel 2
Health

Popular Blood Pressure Tablets Under Class II Recall – WSB-TV Channel 2

Stephen Atcheler
By Stephen Atcheler
November 4, 2026 1 Min Read
Comments Off on Popular Blood Pressure Tablets Under Class II Recall – WSB-TV Channel 2

If you are taking blood pressure medication, you will need to check your prescriptions. The Food and Drug Administration has announced the recall of a popular treatment.

The agency said Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets had been recalled.

The Mayo Clinic said the pill is a combination of medications that can be used alone or in combination with others for high blood pressure.

Olmesartan is an angiotensin II receptor blocker, while amlodipine is a calcium channel blocker and hydrochlorothiazide is a diuretic, the Mayo Clinic said.

They did not meet dissolution specifications.

The recall concerns two lots: 2251163A, expiry date 05/31/2027 and 12251163B, expiry date 05/31/2027. They were distributed throughout the country.

The FDA said the recall affected 3,528 30-count bottles and 216 90-count bottles.

The drugs were initially recalled on October 7, but the FDA classified them as a Class II recall on October 26.

A Class II recall is “a situation in which use of or exposure to an infringing product may result in temporary or medically reversible adverse health consequences, or in which the likelihood of serious adverse health consequences is low.”

©2026 Cox Media Group

Gn Health

Views: 6
Stephen Atcheler
Author

Stephen Atcheler

**Stephen** is a staff journalist at **DailyVoxa**, specializing in business, finance, technology, artificial intelligence, and global markets. He is committed to delivering timely, accurate, and insightful reporting that helps readers understand the forces shaping the global economy and the rapidly evolving digital landscape.Drawing on in-depth research and credible sources, Stephen covers breaking developments, industry trends, and emerging innovations with a focus on clarity, balance, and factual accuracy. His reporting is designed to provide readers with reliable information, practical context, and thoughtful analysis without sensationalism.As a member of the DailyVoxa editorial team, Stephen follows the publication's Editorial Policy, Fact-Checking Policy, Corrections Policy, and Ethics Policy. Every article is carefully reviewed to ensure it meets the highest standards of journalistic integrity, transparency, and editorial independence.

Follow Me
Other Articles
Gronk and Floyd Mayweather at New Hampshire polling stations
Previous

Gronk and Floyd Mayweather at New Hampshire polling stations

Israel's political impasse leaves Netanyahu's future in the balance | Israel Elections 2026 News
Next

Israel’s political impasse leaves Netanyahu’s future in the balance | Israel Elections 2026 News

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.
  • About Us
  • Accessibility Statement
  • Advertise With Us
  • AI Usage & Transparency Policy
  • Contact us
  • Cookie Policy
  • Corrections Policy
  • Meet Our Team
  • Privacy Policy
    • Disclaimer
    • DMCA & Copyright Policy
    • Editorial Policy
    • Ethics Policy
    • Fact-Checking Policy
  • Terms and Conditions
Copyright 2026 — Today's News. Tomorrow's Perspective.. All rights reserved.